Englewood Lab, Inc.

KOSDAQ:A950140 Stock Report

Market Cap: ₩153.2b

Englewood Lab Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Englewood Lab.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Professional Services earnings growth23.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Englewood Lab, Inc. (KOSDAQ:950140) Might Not Be As Mispriced As It Looks After Plunging 30%

Nov 11
Englewood Lab, Inc. (KOSDAQ:950140) Might Not Be As Mispriced As It Looks After Plunging 30%

Not Many Are Piling Into Englewood Lab, Inc. (KOSDAQ:950140) Stock Yet As It Plummets 30%

Nov 11
Not Many Are Piling Into Englewood Lab, Inc. (KOSDAQ:950140) Stock Yet As It Plummets 30%

Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing

Aug 07
Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing

We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease

Jun 20
We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease

Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?

May 24
Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?

A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb

May 09
A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb

Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital

May 08
Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital

When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?

Apr 16
When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?

There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital

Mar 31
There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital

If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns

Mar 17
If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns

What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?

Feb 23
What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?

These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well

Feb 05
These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well

Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20
Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?

Jan 02
Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?

Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture

Dec 15
Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture

Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 26
Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Englewood Lab has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A950140 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024197,00014,915-5374,772N/A
6/30/2024210,04322,3162,2327,650N/A
3/31/2024213,47322,7416,65810,661N/A
12/31/2023206,78420,74218,03720,640N/A
9/30/2023190,93917,19223,63627,234N/A
6/30/2023177,68814,06119,49123,174N/A
3/31/2023166,12511,30122,45626,348N/A
12/31/2022151,5097,2655,3369,562N/A
9/30/2022143,92611,808-5,042-3,077N/A
6/30/2022146,66112,314-1,981404N/A
3/31/2022159,04313,893-14,289-11,997N/A
12/31/2021160,81614,997-9,343-6,864N/A
9/30/2021166,31712,786-4,777-2,406N/A
6/30/2021159,2039,004-6971,365N/A
3/31/2021139,6964,1763,4166,609N/A
12/31/2020137,1683,0823,3137,298N/A
9/30/2020134,2532,0095,0019,739N/A
6/30/2020126,9957241,7057,965N/A
3/31/2020133,4813,3095,77511,284N/A
12/31/2019133,3172,2697,16812,116N/A
9/30/2019126,613-4,1064,68710,298N/A
6/30/2019136,254-650-2,7021,409N/A
3/31/2019125,828-5,351-9,497-4,718N/A
12/31/2018118,766-5,899-22,584-9,368N/A
9/30/2018112,935-4,124-23,793-11,128N/A
6/30/201894,598-12,425N/A-10,929N/A
3/31/201891,216-15,941N/A-12,338N/A
12/31/201787,135-13,878N/A-8,981N/A
9/30/201784,174-11,583N/A-6,358N/A
6/30/201786,487-7,618N/A-5,043N/A
3/31/201783,275516N/A-2,861N/A
12/31/201679,182-284N/A-3,506N/A
12/31/2015143,13613,267N/A-1,128N/A
12/31/201438,9954,395N/A6,339N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A950140's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A950140's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A950140's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A950140's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A950140's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A950140's Return on Equity is forecast to be high in 3 years time


Discover growth companies